메뉴 건너뛰기




Volumn 16, Issue 1, 2016, Pages

Ferumoxytol versus iron sucrose treatment: A post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia

Author keywords

Chronic kidney disease; Ferumoxytol; Hemoglobin; Iron deficiency anemia; Iron sucrose

Indexed keywords

ANTIANEMIC AGENT; FERUMOXYTOL; IRON SACCHARATE;

EID: 85021001781     PISSN: None     EISSN: 20521839     Source Type: Journal    
DOI: 10.1186/s12878-016-0060-x     Document Type: Article
Times cited : (23)

References (15)
  • 1
    • 51849108672 scopus 로고    scopus 로고
    • World Health Organization, Geneva; Accessed 15 Mar 2013
    • World Health Organization. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. World Health Organization, Geneva. 2008. http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. Accessed 15 Mar 2013.
    • (2008) Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia.
  • 3
    • 64049119384 scopus 로고    scopus 로고
    • Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988–2004
    • Fishbane S, Pollack S, Feldman HI, Joffe MM. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988–2004. Clin J Am Soc Nephrol. 2009;4(1):57–61.
    • (2009) Clin J Am Soc Nephrol. , vol.4 , Issue.1 , pp. 57-61
    • Fishbane, S.1    Pollack, S.2    Feldman, H.I.3    Joffe, M.M.4
  • 6
    • 84855897978 scopus 로고    scopus 로고
    • Iron deficiency anaemia: a review of diagnosis, investigation and management
    • Liu K, Kaffes AJ. Iron deficiency anaemia: a review of diagnosis, investigation and management. Eur J Gastroenterol Hepatol. 2012;24(2):109–16.
    • (2012) Eur J Gastroenterol Hepatol. , vol.24 , Issue.2 , pp. 109-116
    • Liu, K.1    Kaffes, A.J.2
  • 7
    • 84867506589 scopus 로고    scopus 로고
    • KDIGO Clinical practice guideline for anemia in chronic kidney disease
    • Kidney Disease Improving Global Outcomes (KDIGO). KDIGO Clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:282–7.
    • (2012) Kidney Int Suppl. , vol.2 , pp. 282-287
  • 8
    • 80051712903 scopus 로고    scopus 로고
    • A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery
    • Bisbe E, Garcia-Erce JA, Diez-Lobo AI, Munoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth. 2011;107(3):477–8.
    • (2011) Br J Anaesth. , vol.107 , Issue.3 , pp. 477-478
    • Bisbe, E.1    Garcia-Erce, J.A.2    Diez-Lobo, A.I.3    Munoz, M.4
  • 9
    • 80052108611 scopus 로고    scopus 로고
    • FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease
    • Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141(3):846–53 e1–2.
    • (2011) Gastroenterology. , vol.141 , Issue.3 , pp. 846-853
    • Evstatiev, R.1    Marteau, P.2    Iqbal, T.3    Khalif, I.L.4    Stein, J.5    Bokemeyer, B.6
  • 10
    • 84897463862 scopus 로고    scopus 로고
    • Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial
    • Onken JE, Bregman DB, Harrington RA, Morris D, Buerkert J, Hamerski D, et al. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant. 2014;29(4):833–42.
    • (2014) Nephrol Dial Transplant. , vol.29 , Issue.4 , pp. 833-842
    • Onken, J.E.1    Bregman, D.B.2    Harrington, R.A.3    Morris, D.4    Buerkert, J.5    Hamerski, D.6
  • 11
    • 84873861354 scopus 로고    scopus 로고
    • Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: two randomized, controlled trials
    • Barish CF, Koch T, Butcher A, Morris D, Bregman DB. Safety and efficacy of intravenous ferric carboxymaltose (750 mg) in the treatment of iron deficiency anemia: two randomized, controlled trials. Anemia. 2012;2012:172104.
    • (2012) Anemia. , vol.2012
    • Barish, C.F.1    Koch, T.2    Butcher, A.3    Morris, D.4    Bregman, D.B.5
  • 12
    • 84884235116 scopus 로고    scopus 로고
    • Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia
    • Hussain I, Bhoyroo J, Butcher A, Koch TA, He A, Bregman DB. Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia. Anemia. 2013;2013:169107.
    • (2013) Anemia. , vol.2013
    • Hussain, I.1    Bhoyroo, J.2    Butcher, A.3    Koch, T.A.4    He, A.5    Bregman, D.B.6
  • 13
    • 85027179627 scopus 로고    scopus 로고
    • Feraheme (ferumoxytol) Injection for Intravenous (IV) use: prescribing information
    • AMAG Pharmaceuticals, Inc.: Waltham, MA; Accessed 4 Jun 2015
    • Feraheme (ferumoxytol) Injection for Intravenous (IV) use: prescribing information. AMAG Pharmaceuticals, Inc.: Waltham, MA. 2015. http://www.amagpharma.com/documents/feraheme-productinsert.pdf. Accessed 4 Jun 2015.
    • (2015)
  • 14
    • 84904054374 scopus 로고    scopus 로고
    • A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD
    • Macdougall IC, Strauss WE, McLaughlin J, Li Z, Dellanna F, Hertel J. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. Clin J Am Soc Nephrol. 2014;9(4):705–12.
    • (2014) Clin J Am Soc Nephrol. , vol.9 , Issue.4 , pp. 705-712
    • Macdougall, I.C.1    Strauss, W.E.2    McLaughlin, J.3    Li, Z.4    Dellanna, F.5    Hertel, J.6
  • 15
    • 84900833291 scopus 로고    scopus 로고
    • A phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
    • Hetzel D, Strauss WE, Bernard K, Li Z, Urboniene A, Allen LF. A phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. Am J Hematol. 2014;89(6):646–50.
    • (2014) Am J Hematol. , vol.89 , Issue.6 , pp. 646-650
    • Hetzel, D.1    Strauss, W.E.2    Bernard, K.3    Li, Z.4    Urboniene, A.5    Allen, L.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.